The Report “In Situ Hybridization Market Study (2014-2019) by Type (DNA ISH, RNA ISH), By Application (Cancer Diagnostics, Immunology, Neurosciences, Cytology, Others), By End User (Hospitals, Pharma & Biotech Companies, Research Labs, CROs)”, the global In-Situ hybridization market was valued at $554.4 million 2014 and is estimated to reach $681.0 million by 2019, at a CAGR of 4.2% during the forecast period, 2014 to 2019.
Browse through the TOC of the global In-Situ Hybridization Market report, to get an idea of the in-depth analysis provided. This also provides a glimpse of the segmentation of the global in-situ hybridization market, supported by various tables and figures.
Early buyers will receive 10% customization on this report
In-Situ hybridization (ISH) is a technique which is used to identify the exact location of a specific segment of nucleic acid that is a DNA, mRNA, or protein within a cell or tissue (In-Situ) so as to obtain information about the gene expression. The underlying basis of ISH is that if the nucleic acids are adequately preserved within a cell or tissue, they can be identified through the application of a complementary strand of nucleic acid to which a reporter molecule is attached. The growth of the global In-Situ hybridization market can be attributed to increasing prevalence of cancer disease along with the growing usage of personalized medicines for its treatment.
Over the years, there has been an increase in the incidences of cancer across the globe. According to a study carried out by GLOBOCAN, in 2012 about 14.1 million new cancer cases and 8.2 million cancer-related deaths were recorded across the world. In-Situ hybridization is mainly used for the diagnosis and management of cancer disease. Thus, with the increasing number of cancer cases being reported worldwide, the global In-Situ hybridization market is expected to grow during the forecast period, 2014 to 2019. North America held the largest share in the global In-Situ hybridization market in 2014 and is projected to grow at a CAGR of 4.0% during the forecast period.
This market has been segmented and forecast on the basis of type, technique, application, end user, and geography. Based on type, the global in-situ hybridization market has been segmented into DNA in-situ hybridization and RNA in-situ hybridization. The DNA in-situ hybridization segment led the global In-Situ hybridization market in 2014 and is estimated to reach $505.8 million by 2019. Both the types have been further sub-segmented on the basis of techniques into fluorescence in-situ hybridization (FISH) and chromogenic in-situ hybridization (CISH). Among these sub-segments, the fluorescence in-situ hybridization (FISH) segment led the global In-Situ hybridization market in 2014 and is estimated to reach $375.6 million by 2019.
This report also includes the market share, value chain analyses, and market metrics, such as drivers, restraints, and upcoming opportunities in the market. In addition, it also presents competitive landscape and company profiles of the key players operating in the global In-Situ hybridization market including major companies which deal in in-situ hybridization products.
About MicroMarket Monitor:
MicroMarket Monitor identifies and attends to various unmet needs of different industrial verticals, which include value chain impact analysis. The company publishes about 12000 Market Research Reports on various Micro Markets across the world. The graphical nature and multidimensional analysis of these reports provide advanced Business Intelligence Tools to the clients in that particular target market.
Contact:
Mr. Chandrasekhar K.
UNIT no 802, Tower No. 7, SEZ
Magarpatta City, Hadapsar
Pune, Maharashtra 411013, India
Tel: +1-888-502-0539
Email: sales@micromarketmonitor.com
